Scinovex
articleTop 1% cited

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

Nature Genetics · 2009 · Vol. 41(10) · pp. 1105–1109
Yasuhito TanakaNao NishidaMasaya SugiyamaMasayuki KurosakiKentaro MatsuuraNaoya SakamotoMina NakagawaMasaaki KorenagaKeisuke HinoShuhei HigeYoshito ItoEiji MitaEiji TanakaSatoshi MochidaYoshikazu MurawakiMasao HondaAkito SakaiYoichi HiasaShuhei NishiguchiAsako KoikeIsao SakaidaMasatoshi ImamuraKiyoaki ItoKoji YanoNaohiko MasakiFuminaka SugauchiNamiki IzumiKatsushi TokunagaMasashi Mizokami
Hepatitis C virus researchLiver Disease Diagnosis and TreatmentHepatitis B Virus StudiesRibavirinPegylated interferonBiologyGenome-wide association studyVirologyChronic hepatitisHepatitis CInterferonHepacivirusHepatitis C virus

MeSH terms

Interferon LambdaAllelesAntiviral AgentsChromosomes, Human, Pair 19Drug CombinationsFemaleHaplotypesHumansInterferonsInterleukinsMaleRibavirinGenome, HumanTreatment OutcomeInterferon-alpha
Citations
2,134
FWCI
130.63
field-weighted impact
References
24
Percentile
100%
vs. same field & year
Citations per year
Cited by
Type I interferons in infectious disease
Nature reviews. Immunology · 2015 · 2,694 citations
Benefits and limitations of genome-wide association studies
Nature Reviews Genetics · 2019 · 2,137 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.